| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Operating Officer +2 more
2 companies
Klein Matthew B. is a Chief Executive Officer at PTCT, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 39 sales. Those positions are worth an estimated $26.9M at current prices.
Our model assigns Klein Matthew B. a middling insider score of 54/100, based on 27 past trades. Over a 12-month horizon, 31.6% of those trades were profitable, with an average 12-month return of -27.8%.
Klein Matthew B.'s largest disclosed position is in PTCT as Chief Executive Officer, worth about $26.3M. The recent filings there lean toward selling, a net 138,873 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 10,292 | $68.57 | $705,722.44 | -2.6% | - | - | |
| May 21, 2026 | CLPT Clearpoint Neuro, Inc. | Director | Sell | 16,000 | $11.59 | $185,440.00 | -25.4% | +36.4% | - | |
| May 14, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 12,572 | $72.95 | $917,153.54 | -3.1% | -0.1% | - | |
| Apr 21, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 2,850 | $70.91 | $202,093.50 | -0.7% | +10.4% | - | |
| Mar 12, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 2,662 | $64.08 | $170,580.96 | -0.7% | +15.8% | - | |
| Feb 18, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 7,371 | $69.36 | $511,252.56 | -1.9% | +2.0% | - | |
| Jan 8, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 2,514 | $76.45 | $192,195.30 | -0.6% | -7.3% | - | |
| Jan 7, 2026 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 8,165 | $77.15 | $629,895.23 | -2.0% | -9.9% | - | |
| Dec 30, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 8,089 | $76.64 | $619,940.96 | -2.3% | -13.8% | - | |
| Dec 2, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 3,428 | $79.07 | $271,051.96 | -1.0% | -15.5% | - |